Seite 2 - Die größten Global Pharmaceuticals & Biotech Aktien nach Marktkapitalisierung

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

AKTUALISIERT Jul 04, 2026

Entdecken Sie die Large-Cap-Unternehmen Global Pharmaceuticals & Biotech aus aller Welt. Diese Pharmaceuticals & Biotech Companies sind nach Marktkapitalisierung geordnet.

3,008 Unternehmen

Unternehmen	Letzter Preis	7D Rückkehr	1J Rückkehr	Marktkapitalisierung	Analysten Ziel	Bewertung	Wachstum	Div. Rendite
600276	CN¥54.45	11.9%	2.2%	CN¥359.8b	CN¥81.14	44.4	16.5%	0.4%
4502	JP¥5,359.00	5.3%	20.7%	JP¥8.5t	JP¥6,106.87	1.9	38.6%	3.8%
GALD	CHF 179.55	0.7%	53.1%	CHF 42.1b	CHF 186.11	85.5	24.5%	0.2%
LONN	CHF 574.20	7.4%	2.5%	CHF 40.1b	CHF 665.48	44.1	17.5%	0.9%
SUNPHARMA	₹1,904.80	2.3%	13.6%	₹4.6t	₹2,047.35	39.8	14.7%	0.8%
A207940	₩1,421,000.00	5.8%	-11.0%	₩65.8t	₩2,056,533.80	37.5	12.0%	23.1%
HLN	UK£3.64	4.6%	-3.6%	UK£32.1b	UK£4.14	19.3	6.3%	1.9%
ALNY	US$312.78	7.3%	-5.8%	US$41.8b	US$434.72	77.6	27.9%	n/a
CSL	AU$121.81	6.0%	-49.8%	AU$58.3b	AU$140.13	29.0	33.4%	3.5%
TEVA	US$34.64	4.3%	103.6%	US$40.3b	US$40.90	25.8	16.2%	0%
RVMD	US$189.24	3.9%	399.7%	US$40.2b	US$197.18	26.8	59.3%	n/a
NTRA	US$279.32	6.6%	72.7%	US$40.0b	US$264.57	16.0	58.1%	n/a
SDZ	CHF 72.34	0.6%	65.8%	CHF 31.3b	CHF 70.70	42.6	16.9%	1.1%
WAT	US$379.29	1.3%	8.3%	US$37.2b	US$402.87	82.8	25.3%	n/a
A	US$130.69	-3.9%	7.7%	US$36.9b	US$160.33	26.1	12.2%	0.8%
4578	JP¥11,300.00	3.7%	66.9%	JP¥5.9t	JP¥12,900.00	15.8	4.7%	1.2%
IQV	US$207.04	8.3%	26.1%	US$34.6b	US$226.47	24.9	13.1%	n/a
RPRX	US$57.77	2.7%	58.8%	US$33.3b	US$59.25	31.0	38.8%	1.6%
ONC	US$297.65	6.3%	21.2%	US$33.1b	US$412.38	64.5	29.2%	n/a
BIIB	US$216.12	0.04%	62.7%	US$31.9b	US$220.28	23.3	12.1%	n/a
MRNA	US$79.76	18.6%	161.6%	US$31.6b	US$45.85	14.2	53.6%	n/a
ZTS	US$74.80	-1.7%	-53.0%	US$31.4b	US$118.29	11.7	5.2%	2.8%
4568	JP¥2,649.50	4.5%	-17.8%	JP¥4.7t	JP¥4,205.29	18.2	12.7%	3.8%
ILMN	US$188.68	6.9%	87.2%	US$28.5b	US$153.26	33.5	9.8%	n/a

Page 2 of 126